Effects of inhalation of the hydrogen-rich gas before sleep on fatigue recovery in healthy adults
Li Q, Li Y, Liu H, Wang Y, Bao D, Liu H, Zhou J · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 100 healthy participants with no sleep disorders, no significant difference in the percent change of HRV paraments (i.e., LF/HF, RMSSD, SDNN, LF average, HF average, VLF average) and KSS scale from night to morning were observed between CS and HS ( p > 0.67). These findings add human evidence that helps define the outcomes that did and did not change with molecular hydrogen in this study.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 100 healthy participants with no sleep disorders. No significant difference in the percent change of HRV paraments (i.e., LF/HF, RMSSD, SDNN, LF average, HF average, VLF average) and KSS scale from night to morning were observed between CS and HS ( p > 0.67).
What the Researchers Studied
The researchers studied 100 healthy participants with no sleep disorders. The study used a human clinical study.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 20 minutes. No significant difference in the percent change of HRV paraments (i.e., LF/HF, RMSSD, SDNN, LF average, HF average, VLF average) and KSS scale from night to morning were observed between CS and HS ( p > 0.67).
Why These Findings Matter
This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 100 healthy participants with no sleep disorders. The reported sample size was 100. The study used a human clinical study. The reported treatment duration was 20 minutes.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://europepmc.org/article/PPR/PPR842197.